GSK’s Jemperli Delivers Promising Interim Data in Rectal Cancer
GSK plc GSK has announced positive interim data from a mid-stage study evaluating its oncology drug, Jemperli (dostarlimab), in…
FDA Accepts AstraZeneca’s Filing for Expanded Use of Ultomiris
AstraZeneca AZN announced that the FDA has accepted a regulatory filing seeking to expand the use of its blockbuster…